Diclofenac Should Not Be Given 4 Hours After Meftal (Mefenamic Acid)
Diclofenac should not be administered 4 hours after mefenamic acid (Meftal) as this combination of two NSAIDs increases the risk of adverse effects without providing additional analgesic benefit. 1, 2
Pharmacological Considerations
- Both diclofenac and mefenamic acid are non-steroidal anti-inflammatory drugs (NSAIDs) that work through similar mechanisms by inhibiting cyclooxygenase enzymes and reducing prostaglandin synthesis 3
- Combining two NSAIDs does not provide additional analgesic efficacy but significantly increases the risk of adverse effects, particularly gastrointestinal toxicity 1, 2
- Mefenamic acid has a half-life of approximately 2-4 hours, meaning it would still be active in the system 4 hours after administration 2, 4
- Diclofenac has a relatively short elimination half-life in plasma (1.5 hours) but persists longer in tissues and synovial fluid 3
Safety Concerns with NSAID Combinations
- Concurrent use of multiple NSAIDs increases the risk of:
Alternative Approach
- If additional pain relief is needed after mefenamic acid, consider using a non-NSAID analgesic such as acetaminophen/paracetamol 1
- The combination of NSAIDs with acetaminophen improves the quality of pain relief compared to using either drug alone 1
- If stronger analgesia is required, consider adding a weak opioid according to the WHO pain ladder rather than a second NSAID 1
Special Considerations
- For patients requiring anti-inflammatory effects for conditions like rheumatoid arthritis or osteoarthritis, a single NSAID at an appropriate dose is recommended rather than combining multiple NSAIDs 3
- If mefenamic acid is not providing adequate pain relief, it would be more appropriate to discontinue it and switch to diclofenac rather than adding it on top 2
- Patients taking aspirin for cardioprotection should be aware that NSAIDs may interfere with aspirin's cardioprotective effects 1
Monitoring and Precautions
- If NSAIDs are used over a prolonged period, gastric protection is recommended 1
- Caution is needed in patients with renal impairment, cardiovascular disease, or risk factors for gastrointestinal bleeding 1
- Monitoring for signs of gastrointestinal, renal, or cardiovascular adverse effects is essential when using any NSAID 1
In conclusion, rather than combining two NSAIDs (diclofenac and mefenamic acid), a more appropriate approach would be to either continue with one NSAID at an optimal dose or switch to a different analgesic class if additional pain relief is needed.